Compare PLYX & VFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLYX | VFF |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.8M | 314.1M |
| IPO Year | N/A | 2013 |
| Metric | PLYX | VFF |
|---|---|---|
| Price | $3.68 | $2.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 146.1K | ★ 1.1M |
| Earning Date | 05-22-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 184.38 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $215,937,000.00 |
| Revenue This Year | N/A | $12.19 |
| Revenue Next Year | N/A | $15.82 |
| P/E Ratio | ★ N/A | $130.75 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.20 | $1.04 |
| 52 Week High | $9.18 | $4.99 |
| Indicator | PLYX | VFF |
|---|---|---|
| Relative Strength Index (RSI) | 43.07 | 44.23 |
| Support Level | $2.58 | $2.50 |
| Resistance Level | $7.29 | $2.94 |
| Average True Range (ATR) | 0.61 | 0.13 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 38.96 | 31.25 |
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.